Abstract
We developed a high-performance liquid chromatographic assay to measure ceftriaxone in serum, urine, and cerebrospinal fluid. Ion pairing was used because ceftriaxone is a relatively polar compound which is poorly retained on C18 columns in standard reverse-phase high-performance liquid chromatography and which produces trailing peaks in the absence of ion-pairing agents. The mobile phase was a combination of acetonitrile and water (46:54), adjusted to pH 9.0 with 10 mM K2HPO4, which contained 10 mM hexadecyltrimethylammonium bromide as the ion-pairing agent. Moxalactam (200 micrograms/ml) was used as the internal standard. A silica-packed precolumn (3 cm long) was used to prevent rapid deterioration of the analytical column (30 by 0.4 cm) by the alkaline pH of the mobile phase, and it significantly extended the life of the analytical column. The assay was linear with ceftriaxone concentrations of 1 to 250 micrograms/ml (r = 0.999) and correlated well with an agar diffusion bioassay (r = 0.990). Reproducibility was good, with intrarun coefficients of variation from 2.3 to 6.4% and interrun coefficients of variation from 3.2 to 21.4%. The absolute recoveries of ceftriaxone and moxalactam were 91 to 97 and 96 to 98%, respectively. No interferences were observed with more than 40 commonly prescribed drugs, including 10 cephalosporins (cefotaxime, cefoperazone, ceftazidime, ceftizoxime, cefoxitin, cefamandole, cephalothin, cefazolin, cephapirin, and cephalexin), or with sera from patients with renal or hepatic disease.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ascalone V., Dal Bò L. Determination of ceftriaxone, a novel cephalosporin, in plasma, urine and saliva by high-performance liquid chromatography on an NH2 bonded-phase column. J Chromatogr. 1983 Apr 8;273(2):357–366. doi: 10.1016/s0378-4347(00)80956-1. [DOI] [PubMed] [Google Scholar]
- Bowman D. B., Aravind M. K., Miceli J. N., Kauffman R. E. Reversed-phase high-performance liquid chromatographic method to determine ceftriaxone in biological fluids. J Chromatogr. 1984 Jul 13;309(1):209–213. doi: 10.1016/0378-4347(84)80027-4. [DOI] [PubMed] [Google Scholar]
- Cleeland R., Squires E. Antimicrobial activity of ceftriaxone: a review. Am J Med. 1984 Oct 19;77(4C):3–11. [PubMed] [Google Scholar]
- Giese R. W. Technical considerations in the use of "high-performance" liquid chromatography in therapeutic drug monitoring. Clin Chem. 1983 Jul;29(7):1331–1343. [PubMed] [Google Scholar]
- Patel I. H., Kaplan S. A. Pharmacokinetic profile of ceftriaxone in man. Am J Med. 1984 Oct 19;77(4C):17–25. [PubMed] [Google Scholar]
- Pfaller M. A., Krogstad D. J., Granich G. G., Murray P. R. Laboratory evaluation of five assay methods for vancomycin: bioassay, high-pressure liquid chromatography, fluorescence polarization immunoassay, radioimmunoassay, and fluorescence immunoassay. J Clin Microbiol. 1984 Sep;20(3):311–316. doi: 10.1128/jcm.20.3.311-316.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Poretz D. M., Woolard D., Eron L. J., Goldenberg R. I., Rising J., Sparks S. Outpatient use of ceftriaxone: a cost-benefit analysis. Am J Med. 1984 Oct 19;77(4C):77–83. [PubMed] [Google Scholar]
- Tan J. S., Salstrom S. J., File T. M. Diffusibility of the newer cephalosporins into human interstitial fluids. Am J Med. 1984 Oct 19;77(4C):33–36. [PubMed] [Google Scholar]
- Tanner D. J., Nazarian M. Q. Cost containment associated with decreased parenteral antibiotic administration frequencies. Am J Med. 1984 Oct 19;77(4C):104–111. [PubMed] [Google Scholar]
- Westgard J. O., Hunt M. R. Use and interpretation of common statistical tests in method-comparison studies. Clin Chem. 1973 Jan;19(1):49–57. [PubMed] [Google Scholar]